q3 earnings per share $129.96.
sees fy non-gaap revenue growth 12% to 13% versus prior guidance of 10% to 10.5%.
q3 sales $747 million versus refinitiv ibes estimate of $647.3 million.
q3 non-gaap earnings per share $3.71.
sees fy covid-related sales $240 million to $245 million.
qtrly sales rose 13.8 percent on a currency neutral basis to $13.8 billion.
q3 operating income $156.8 million versus refinitiv ibes estimate of $144.6 million.
q3 sales $373.5 million versus refinitiv ibes estimate of $324.9 million.